swertiajaponin

from Cymbopogon citratus; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Dwivedi, Prarambh S R: 1 article (01/2021)
2.	Gaonkar, Vishakha Parab: 1 article (01/2021)
3.	Khanal, Pukar: 1 article (01/2021)
4.	Patil, B M: 1 article (01/2021)
5.	Rasal, V P: 1 article (01/2021)
6.	Braga, Fernão Castro: 1 article (03/2016)
7.	Dourado, Luana Pereira Antunes: 1 article (03/2016)
8.	Garcia, Eliana de Faria: 1 article (03/2016)
9.	Teixeira, Mauro Martins: 1 article (03/2016)
10.	de Oliveira, Mariana Assíria: 1 article (03/2016)

1.	Necrosis 03/01/2016 - "Polynomial regression analysis showed the association between the contents of swertiajaponin, swertisin, trans-aconitic, and chicoric acids with the antitumor necrosis factor-α activity of the extracts and fractions. "
2.	Diabetes Mellitus 01/01/2021 - "Swertiajaponin could act as the potent inhibitor of PTP1B; scored highest druglikeness score but possessed minimum GIT absorptivity; further, PTP1B was identified to be linked with multiple pathways that are concerned with diabetes mellitus."